Shareholders of ‘Beni-koji’ Scandal-Hit Pharmaceutical Company Approve Board Nominees
Shareholders of Kobayashi Pharmaceutical Co. on Friday approved the company’s proposed slate of 10 board nominees, including executive officer Norikazu Toyoda, who is set to become new president and CEO of the scandal-tainted Japanese company.






